Literature DB >> 14630601

Risk factors for progression to incident hyperinsulinemia: the Atherosclerosis Risk in Communities Study, 1987-1998.

Mercedes R Carnethon1, Stephen P Fortmann, Latha Palaniappan, Bruce B Duncan, Maria I Schmidt, Lloyd E Chambless.   

Abstract

Hyperinsulinemia is a marker of insulin resistance, a correlate of the metabolic syndrome, and an established precursor of type 2 diabetes. This US study investigated the role of risk factors associated with hyperinsulinemia in cross-sectional studies in progression to incident hyperinsulinemia. Nondiabetic participants from the Atherosclerosis Risk in Communities Study (n = 9,020) were followed from 1987 to 1998 for the development of hyperinsulinemia (fasting serum insulin > or = 90th percentile, 19.1 micro U/ml). After adjustment for demographic characteristics, all risk factors simultaneously, and baseline insulin value, the risk of progressing to hyperinsulinemia increased per standard deviation increase in baseline uric acid (odds ratio (OR) = 1.3, 95% confidence interval (CI): 1.2, 1.4; per 1.4 mg/dl) and waist/hip ratio (OR = 1.4, 95% CI: 1.2, 1.5; per 0.08) and was inversely associated with high density lipoprotein cholesterol (OR = 0.8, 95% CI: 0.7, 0.9; per 0.4 mmol/liter). Starting to smoke (OR = 1.5, 95% CI: 1.2, 2.0) and becoming obese (OR = 2.4, 95% CI: 1.8, 3.1) during the study were also associated with increased risk. The associations were similar across race and gender groups. These data suggest that, in addition to weight gain, hyperuricemia, dyslipidemia, and smoking can be detected prior to development of hyperinsulinemia.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14630601     DOI: 10.1093/aje/kwg260

Source DB:  PubMed          Journal:  Am J Epidemiol        ISSN: 0002-9262            Impact factor:   4.897


  31 in total

1.  Purine-rich foods, protein intake, and the prevalence of hyperuricemia: the Shanghai Men's Health Study.

Authors:  R Villegas; Y-B Xiang; T Elasy; W H Xu; H Cai; Q Cai; M F Linton; S Fazio; W Zheng; X-O Shu
Journal:  Nutr Metab Cardiovasc Dis       Date:  2011-01-28       Impact factor: 4.222

2.  Serum uric acid and cardiovascular disease.

Authors:  Adriana Iliesiu; Alexandru Campeanu; Dinu Dusceac
Journal:  Maedica (Buchar)       Date:  2010-07

3.  Ten-year change in serum uric acid and its relation to changes in other metabolic risk factors in young black and white adults: the CARDIA study.

Authors:  Wolfgang Rathmann; Burkhard Haastert; Andrea Icks; Guido Giani; Jeffrey M Roseman
Journal:  Eur J Epidemiol       Date:  2007-05-05       Impact factor: 8.082

Review 4.  Uric Acid - key ingredient in the recipe for cardiorenal metabolic syndrome.

Authors:  Kunal Chaudhary; Kunal Malhotra; James Sowers; Annayya Aroor
Journal:  Cardiorenal Med       Date:  2013-10       Impact factor: 2.041

5.  Independent impact of gout on the risk of diabetes mellitus among women and men: a population-based, BMI-matched cohort study.

Authors:  Young Hee Rho; Na Lu; Christine E Peloquin; Ada Man; Yanyan Zhu; Yuqing Zhang; Hyon K Choi
Journal:  Ann Rheum Dis       Date:  2014-10-02       Impact factor: 19.103

Review 6.  A novel mutation in gene of PRPS1 in a young Chinese woman with X-linked gout: a case report and review of the literature.

Authors:  Bo-Yun Yang; Han-Xiao Yu; Jie Min; Xiao-Xiao Song
Journal:  Clin Rheumatol       Date:  2019-11-26       Impact factor: 2.980

7.  Risk of incident diabetes in patients with gout: a cohort study.

Authors:  Seoyoung C Kim; Jun Liu; Daniel H Solomon
Journal:  Arthritis Rheumatol       Date:  2015-01       Impact factor: 10.995

8.  Clinical study on treatment of hyperuricaemia by retention enema of Chinese herbal medicine combined with allopurinol.

Authors:  Qian Chen; Li Ma; Wupu Akebaier
Journal:  Chin J Integr Med       Date:  2010-01-18       Impact factor: 1.978

9.  Serum uric acid is an independent predictor of metabolic syndrome in a Japanese health screening population.

Authors:  Eiji Oda
Journal:  Heart Vessels       Date:  2013-06-28       Impact factor: 2.037

Review 10.  Uric acid and cardiovascular risk.

Authors:  Daniel I Feig; Duk-Hee Kang; Richard J Johnson
Journal:  N Engl J Med       Date:  2008-10-23       Impact factor: 91.245

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.